Lower Drug Costs for Families Act
The summary
What this bill does
Lower Drug Costs for Families Act
This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.
Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.
The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
Legislative timeline
From introduction
Apr 1, 2025
Introduced & referred to committee
Congressional support
Sponsors & Cosponsors
U.S. Representative - NV District 4 · D-NV
Roll-call vote
The vote, by member
The vote, by member
VERSION CHANGES
What changed,
and where.
Loading the bill text comparison.
Bill Metadata
| Congress | 119 |
| Bill Type | HR |
| Bill Number | 2554 |
| Origin Chamber | House |
| Current Status | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| Policy Area | Health |
| Primary Committee | Not assigned |
| Introduced | April 1, 2025 |
| Latest Action | April 1, 2025 |
| Cosponsors | 2 · House vote — · — views |